Eli Lilly and Co (LLY)
747.82
-2.10
(-0.28%)
USD |
NYSE |
Nov 22, 16:00
747.05
-0.77
(-0.10%)
After-Hours: 20:00
Eli Lilly Cash from Investing (Quarterly): -4.005B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.005B |
| June 30, 2024 | -2.199B |
| March 31, 2024 | -1.178B |
| December 31, 2023 | -2.924B |
| September 30, 2023 | -3.080B |
| June 30, 2023 | -459.10M |
| March 31, 2023 | -688.80M |
| December 31, 2022 | -943.50M |
| September 30, 2022 | -955.30M |
| June 30, 2022 | -826.50M |
| March 31, 2022 | -1.038B |
| December 31, 2021 | -484.20M |
| September 30, 2021 | -616.50M |
| June 30, 2021 | -483.30M |
| March 31, 2021 | -1.284B |
| December 31, 2020 | -674.10M |
| September 30, 2020 | -313.50M |
| June 30, 2020 | -210.40M |
| March 31, 2020 | -1.061B |
| December 31, 2019 | -41.40M |
| September 30, 2019 | -423.80M |
| June 30, 2019 | 61.00M |
| March 31, 2019 | -7.679B |
| December 31, 2018 | -659.00M |
| September 30, 2018 | -398.10M |
| Date | Value |
|---|---|
| June 30, 2018 | 3.133B |
| March 31, 2018 | -170.30M |
| December 31, 2017 | 1.653B |
| September 30, 2017 | -1.758B |
| June 30, 2017 | -2.249B |
| March 31, 2017 | -1.430B |
| December 31, 2016 | -1.178B |
| September 30, 2016 | -794.70M |
| June 30, 2016 | -1.021B |
| March 31, 2016 | -145.40M |
| December 31, 2015 | 253.70M |
| September 30, 2015 | -570.10M |
| June 30, 2015 | 182.40M |
| March 31, 2015 | 160.80M |
| December 31, 2014 | -2.179B |
| September 30, 2014 | -1.650B |
| June 30, 2014 | -468.90M |
| March 31, 2014 | 388.40M |
| December 31, 2013 | -1.232B |
| September 30, 2013 | -943.80M |
| June 30, 2013 | -1.252B |
| March 31, 2013 | 1.355B |
| December 31, 2012 | -1.662B |
| September 30, 2012 | -132.70M |
| June 30, 2012 | -385.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.005B
Minimum
Sep 2024
-41.40M
Maximum
Dec 2019
-1.173B
Average
-885.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen Inc | -210.00M |
| Biogen Inc | -1.181B |
| Johnson & Johnson | -3.128B |
| Viking Therapeutics Inc | 25.90M |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.712B |
| Cash from Financing (Quarterly) | 211.30M |
| Free Cash Flow | -2.275B |
| Free Cash Flow Per Share (Quarterly) | -0.5071 |
| Free Cash Flow to Equity (Quarterly) | -2.687B |
| Free Cash Flow to Firm (Quarterly) | -370.39M |
| Free Cash Flow Yield | -0.34% |